Home
About
FAQ
History (51)
Central and Peripheral Determinants of Exercise Capacity in Heart Failure Patients With Preserved Ejection Fraction.
Adrenodoxin
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer’s Disease
Zosteraceae
Beta-Zn(3)(AsO(3))(2).
See All 51 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Beta-Zn(3)(AsO(3))(2).
Harrison WT. Beta-Zn(3)(AsO(3))(2). Acta Crystallogr C. 2010 Jun; 66(Pt 6):i64-6.
View in:
PubMed
authors with profiles
William T. Harrison MD